164 related articles for article (PubMed ID: 18386053)
1. Sarcoma of follicular dendritic cells with features of sinus lining cells--a new subtype of reticulum cell sarcoma?
Krokowski M; Merz H; Thorns C; Bernd HW; Schade U; Le Tourneau A; Diebold J; Feller AC
Virchows Arch; 2008 May; 452(5):565-70. PubMed ID: 18386053
[TBL] [Abstract][Full Text] [Related]
2. LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes.
Wróbel T; Dziegiel P; Mazur G; Zabel M; Kuliczkowski K; Szuba A
Lymphology; 2005 Sep; 38(3):107-10. PubMed ID: 16353487
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease.
Sun X; Chang KC; Abruzzo LV; Lai R; Younes A; Jones D
Hum Pathol; 2003 Sep; 34(9):835-40. PubMed ID: 14562277
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell neoplasms: an overview.
Kairouz S; Hashash J; Kabbara W; McHayleh W; Tabbara IA
Am J Hematol; 2007 Oct; 82(10):924-8. PubMed ID: 17636477
[TBL] [Abstract][Full Text] [Related]
5. Reticulum cell sarcoma of lymph node with mixed dendritic and fibroblastic features.
Jones D; Amin M; Ordonez NG; Glassman AB; Hayes KJ; Medeiros LJ
Mod Pathol; 2001 Oct; 14(10):1059-67. PubMed ID: 11598178
[TBL] [Abstract][Full Text] [Related]
6. [Follicular dendritic reticulum cell sarcoma in a cervical lymph node].
Riedel F; Back W; Götte K; Hörmann K
HNO; 2001 Oct; 49(10):837-41. PubMed ID: 11699145
[TBL] [Abstract][Full Text] [Related]
7. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors.
Grogg KL; Lae ME; Kurtin PJ; Macon WR
Am J Surg Pathol; 2004 Aug; 28(8):988-98. PubMed ID: 15252304
[TBL] [Abstract][Full Text] [Related]
8. Interdigitating dendritic reticulum cell sarcoma: cytologic, histologic and immunocytochemical features.
Jayaram G; Mun KS; Elsayed EM; Sangkar JV
Diagn Cytopathol; 2005 Jul; 33(1):43-8. PubMed ID: 15945093
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
Yu H; Gibson JA; Pinkus GS; Hornick JL
Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
[TBL] [Abstract][Full Text] [Related]
10. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
11. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.
Johnson LA; Banerji S; Lawrance W; Gileadi U; Prota G; Holder KA; Roshorm YM; Hanke T; Cerundolo V; Gale NW; Jackson DG
Nat Immunol; 2017 Jul; 18(7):762-770. PubMed ID: 28504698
[TBL] [Abstract][Full Text] [Related]
13. Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes.
Bianchi R; Russo E; Bachmann SB; Proulx ST; Sesartic M; Smaadahl N; Watson SP; Buckley CD; Halin C; Detmar M
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):108-117. PubMed ID: 27810998
[TBL] [Abstract][Full Text] [Related]
14. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
Zhang XM; Han WX; Wang HY; He Q
World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
[TBL] [Abstract][Full Text] [Related]
15. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
16. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
[TBL] [Abstract][Full Text] [Related]
17. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
[TBL] [Abstract][Full Text] [Related]
18. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.
Lorenzi L; Lonardi S; Petrilli G; Tanda F; Bella M; Laurino L; Rossi G; Facchetti F
Hum Pathol; 2012 Feb; 43(2):209-15. PubMed ID: 21835430
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
El-Gendi S; Abdel-Hadi M
J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
[TBL] [Abstract][Full Text] [Related]
20. A lymph node interdigitating reticulum cell sarcoma.
Rousselet MC; François S; Croué A; Maigre M; Saint-André JP; Ifrah N
Arch Pathol Lab Med; 1994 Feb; 118(2):183-8. PubMed ID: 8311662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
